Sarmadi Mahdieh, Gheibi Azam, Khanahmad Hossein, Khorramizadeh Mohammad Reza, Hejazi Seyed Hossein, Zahedi Noushin, Mianesaz Hamidreza, Kashfi Khosrow
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Department of Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran 14177-55469, Iran.
Vaccines (Basel). 2022 Mar 3;10(3):388. doi: 10.3390/vaccines10030388.
vaccines help control bovine brucellosis. The RB51 strain is a live attenuated vaccine with low side effects compared with other live attenuated brucellosis vaccines, but it provides insufficient protective efficacy. Cell-mediated immune responses are critical in resistance against intracellular bacterial infections. Therefore, we hypothesized that the listeriolysin O (LLO) expression of , BAX, and SMAC apoptotic proteins in strain RB51 could enhance vaccine efficacy and safety. RB51 was transformed separately with two broad-host-range plasmids (pbbr1ori-LLO and pBlu-mLLO-BAX-SMAC) constructed from our recent work. pbbr1ori-LLO contains LLO, and pBlu-mLLO-BAX-SMAC contains the mutant LLO and BAX-SMAC fusion gene. The murine macrophage-like cell line J774A.1 was infected with the RB51 recombinant strain containing pBlu-mLLO-BAX-SMAC, RB51 recombinant strain containing LLO, and RB51 strain. The bacterial cytotoxicity and survival and apoptosis of host cells contaminated with our two strain types-RB51 recombinants or the parental RB51-were assessed. Strain RB51 expressing mLLO and BAX-SMAC was tested in BALB/c mice and a cell line for enhanced modulation of IFN-γ production. LDH analysis showed that the RB51-mLLO-BAX-SMAC and RB51-LLO strains expressed higher cytotoxicity in J774A.1 cells than RB51. In addition, RB51 recombinants had lower macrophage survival rates and caused higher levels of apoptosis and necrosis. Mice vaccinated with the RB51 recombinant containing mLLO-BAX-SMAC showed an enhanced Th1 immune response. This enhanced immune response is primarily due to bacterial endosome escape and bacterial antigens, leading to improved apoptosis and cross-priming. This potentially enhanced TCD- and T cell-mediated immunity leads to the increased safety and potency of the RB51 recombinant (RB51 mLLO-BAX-SMAC) as a vaccine candidate against .
疫苗有助于控制牛布鲁氏菌病。RB51菌株是一种减毒活疫苗,与其他减毒布鲁氏菌病疫苗相比副作用较小,但提供的保护效力不足。细胞介导的免疫反应在抵抗细胞内细菌感染中至关重要。因此,我们假设RB51菌株中李斯特菌溶血素O(LLO)、BAX和SMAC凋亡蛋白的表达可以提高疫苗的效力和安全性。分别用我们近期工作构建的两种广宿主范围质粒(pbbr1ori-LLO和pBlu-mLLO-BAX-SMAC)转化RB51。pbbr1ori-LLO含有LLO,pBlu-mLLO-BAX-SMAC含有突变型LLO和BAX-SMAC融合基因。用含有pBlu-mLLO-BAX-SMAC的RB51重组菌株、含有LLO的RB51重组菌株和RB51菌株感染小鼠巨噬细胞样细胞系J774A.1。评估了被我们的两种菌株类型(RB51重组体或亲本RB51)污染的宿主细胞的细菌细胞毒性以及存活和凋亡情况。在BALB/c小鼠和细胞系中测试了表达mLLO和BAX-SMAC的RB51菌株对IFN-γ产生的增强调节作用。乳酸脱氢酶分析表明,RB51-mLLO-BAX-SMAC和RB51-LLO菌株在J774A.1细胞中的细胞毒性高于RB51。此外,RB51重组体的巨噬细胞存活率较低,导致更高水平的凋亡和坏死。用含有mLLO-BAX-SMAC的RB51重组体接种的小鼠表现出增强的Th1免疫反应。这种增强的免疫反应主要是由于细菌内体逃逸和细菌抗原,导致凋亡改善和交叉启动。这种潜在增强的TCD和T细胞介导的免疫导致RB51重组体(RB51 mLLO-BAX-SMAC)作为抗……疫苗候选物的安全性和效力增加。